Not logged in Share Save
Share Save
Share Save
Share Save
Share Save
Share Save
Share Save
A phase II multicentre study of plasminogen activator inhibitor-1 inhibitor (TM5614) plus nivolumab for treating anti-programmed cell death 1 antibody-refractory malignant melanoma: TM5614-MM trial Fujimura, Taku; Yoshino, Koji; Kato, Hiroshi; Fukushima, Satoshi; Ishizuki, Shoichiro; Otsuka, Atsushi; Matsushita, Shigeto; Amagai, Ryo; Muto, Yusuke; Yamazaki, Emi; Kambayashi, Yumi; Yahata, Takashi; Miyata, Toshio; Fujisawa, Yasuhiro; Asano, Yoshihide Share Save
Plasminogen activator inhibitor-1 promotes immune evasion in tumors by facilitating the expression of programmed cell death-ligand 1 Ibrahim, Abd Aziz; Fujimura, Taku; Uno, Tomoko; Terada, Tomoya; Hirano, Ken-ichi; Hosokawa, Hiroyuki; Ohta, Akio; Miyata, Toshio; Ando, Kiyoshi; Yahata, Takashi Share Save
Share Save
A randomized double-blind placebo-controlled trial of an inhibitor of plasminogen activator inhibitor-1 (TM5614) in mild to moderate COVID-19 Hirai, Toyohiro; Asano, Koichiro; Ito, Isao; Miyazaki, Yasunari; Sugiura, Hisatoshi; Agirbasli, Mehmet; Kobayashi, Seiichi; Kobayashi, Makoto; Shimada, Daishi; Natsume, Ichiro; Kawasaki, Tsutomu; Ohba, Takehiko; Tajiri, Sakurako; Sakamaki, Fumio; Mineshita, Masamichi; Takihara, Takahisa; Sekiya, Kiyoshi; Tomii, Keisuke; Tomioka, Hiromi; Kita, Hideo; Nishizaka, Yasuo; Fukui, Motonari; Miyata, Toshio; Harigae, Hideo Share Save
Efficacy and safety of TM5614 in combination with paclitaxel in the treatment of paclitaxel-resistant cutaneous angiosarcoma: Phase II study protocol Fujimura, Taku; Yoshino, Koji; Nakamura, Motoki; Kato, Hiroshi; Ito, Takamichi; Maekawa, Takeo; Fujisawa, Yasuhiro; Matsushita, Shigeto; Amagai, Ryo; Yamazaki, Emi; Takahashi, Manami; Tamabuchi, Erika; Hashimoto, Akira; Kambayashi, Yumi; Yamazaki, Naoya; Miyata, Toshio; Asano, Yoshihide Share Save
Share Save
Hypoxia Signaling Cascade for Erythropoietin Production in Hepatocytes Tojo, Yutaka; Sekine, Hiroki; Hirano, Ikuo; Pan, Xiaoqing; Souma, Tomokazu; Tsujita, Tadayuki; Kawaguchi, Shin-ichi; Takeda, Norihiko; Takeda, Kotaro; Fong, Guo-Hua; Dan, Takashi; Ichinose, Masakazu; Miyata, Toshio; Yamamoto, Masayuki; Suzuki, Norio Share Save
Pyridoxamine reduces methylglyoxal and markers of glycation and endothelial dysfunction, but does not improve insulin sensitivity or vascular function in abdominally obese individuals: A randomized double-blind placebo-controlled trial Van den Eynde, Mathias D. G.; Houben, Alfons J. H. M.; Scheijen, Jean L. J. M.; Linkens, Armand M. A.; Niessen, Petra M.; Simons, Nynke; Hanssen, Nordin M. J.; Kusters, Yvo H. A. M.; Eussen, Simone J. M. P.; Miyata, Toshio; Stehouwer, Coen D. A.; Schalkwijk, Casper G. Share Save
Pyridoxamine prevents increased atherosclerosis by intermittent methylglyoxal spikes in the aortic arches of ApoE-/- mice Hanssen, Nordin M. J.; Tikellis, Chris; Pickering, Raelene J.; Dragoljevic, Dragana; Lee, Man Kit Sam; Block, Tomasz; Scheijen, Jean L. J. M.; Wouters, Kristiaan; Miyata, Toshio; Cooper, Mark E.; Murphy, Andrew J.; Thomas, Merlin C.; Schalkwijk, Casper G. Share Save
Development and Initial Psychometric Validation of the COVID-19 Pandemic Burden Index for Healthcare Workers Yamamoto, Ryohei; Yamazaki, Hajime; Kobara, Seibi; Iizuka, Hiromi; Hijikata, Yasukazu; Miyashita, Jun; Kataoka, Yuki; Yajima, Nobuyuki; Miyata, Toshio; Hamaguchi, Sugihiro; Wakita, Takafumi; Yamamoto, Yosuke; Fukuhara, Shunichi Share Save
High-sucrose diets contribute to brain angiopathy with impaired glucose uptake and psychosis-related higher brain dysfunctions in mice Hirai, Shinobu; Miwa, Hideki; Tanaka, Tomoko; Toriumi, Kazuya; Kunii, Yasuto; Shimbo, Hiroko; Sakamoto, Takuya; Hino, Mizuki; Izumi, Ryuta; Nagaoka, Atsuko; Yabe, Hirooki; Nakamachi, Tomoya; Shioda, Seiji; Dan, Takashi; Miyata, Toshio; Nishito, Yasumasa; Suzuki, Kazuhiro; Miyashita, Mitsuhiro; Tomoda, Toshifumi; Hikida, Takatoshi; Horiuchi, Junjiro; Itokawa, Masanari; Arai, Makoto; Okado, Haruo Share Save
Share Save
Share Save